Stock Information
Bristol-Myers Squibb Co (BMY)
Ticker Symbol: BMY
Exchange: NYSE
Sector: Pharmaceuticals
Market Cap: $121,330.88 mil
Piotroski score: 8
PE Ratio: 16.9648
EPS (TTM): 3.4598
Revenue (TTM): $23.64 M
Dividend Yield: 4.2374306372961%
ROE: 39.28%
Latest News
-
Potential $5,000 Monthly Income: 12 Investments To Buy And Hold For The Next 10 Years
Sat, Apr 11, 2026 8:10 AM
-
BMY Gains 10% Year to Date: Should You Buy, Sell or Hold the Stock?
Fri, Apr 10, 2026 6:28 PM
-
Assessing Bristol Myers Squibb (BMY) Valuation After Camzyos Data And T Cell Engager Collaboration News
Fri, Apr 10, 2026 6:12 PM
-
BMS and Oxford BioTherapeutics join forces in TCE discovery pact
Fri, Apr 10, 2026 5:32 PM
-
Replimune Stock Tumbles After FDA Rejects Skin Cancer Therapy for Second Time
Fri, Apr 10, 2026 4:57 PM
-
FDA Again Rejects Replimune Skin Cancer Therapy, Says Evidence Falls Short
Fri, Apr 10, 2026 1:57 PM
-
2 Recession Resistant Dividend Stocks to Buy Now While They're Still Cheap
Fri, Apr 10, 2026 10:50 AM
-
Bristol Myers Squibb Cancer Alliance Adds Weight To Valuation Debate
Fri, Apr 10, 2026 8:07 AM
-
Does Cobenfy Have the Potential to Become a Top Drug for BMY?
Thu, Apr 9, 2026 4:13 PM
-
Biopharma Stocks Largely Exempt From Pharma Tariffs, BofA Says
Thu, Apr 9, 2026 3:03 PM
Key Financials
Financial data not available
